Advances in cancer nanovaccines: a focus on colorectal cancer
Authors:
- 5 April 2025
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (9) , 1029-1041
Abstract
Nanotechnology has revolutionized cancer treatment by providing innovative solutions through nanocancer therapies, nanovaccines, and nanoparticles. This review focuses on the application of these technologies in colorectal cancer (CRC), highlighting their progression from preclinical studies to clinical trials. Nanoparticles, including liposomes, silica, gold, and lipid nanoparticles, possess unique properties that enhance drug delivery, improve therapeutic efficacy, and minimize systemic toxicity. Additionally, nanovaccines are being developed to elicit robust immune responses against CRC cells. This paper offers a comprehensive overview of the current state of nanotechnology-based treatments for CRC, emphasizing key preclinical studies and clinical trials that demonstrate their potential. Furthermore, the review discusses the challenges faced in this field. It outlines future directions for research, underscoring the need for ongoing efforts to translate these promising technologies into practical clinical applications.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services
This publication has 119 references indexed in Scilit:
- All‐Trans‐Retinoic Acid‐Adjuvanted mRNA Vaccine Induces Mucosal Anti‐Tumor Immune Responses for Treating Colorectal CancerAdvanced Science, 2024
- Cancer vaccines in the clinicBioengineering & Translational Medicine, 2023
- Biomimetic and bioinspired nano‐platforms for cancer vaccine developmentExploration, 2023
- Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of CancerAdvanced Materials, 2023
- Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid TumorsAdvanced Materials, 2021
- Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic VaccineAdvanced Science, 2021
- Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer ImmunotherapyAdvanced Materials, 2021
- Self‐Adjuvanted Molecular Activator (SeaMac) Nanovaccines Promote Cancer ImmunotherapyAdvanced Healthcare Materials, 2020
- Colorectal Tumor Microenvironment‐Activated Bio‐Decomposable and Metabolizable Cu2O@CaCO3 Nanocomposites for Synergistic OncotherapyAdvanced Materials, 2020
- Engineering Nano‐ and Microparticles to Tune ImmunityAdvanced Materials, 2012